Old Web
English
Sign In
Acemap
>
Paper
>
1044PPembrolizumab in patients with MSI-H advanced endometrial cancer from the KEYNOTE-158 study
1044PPembrolizumab in patients with MSI-H advanced endometrial cancer from the KEYNOTE-158 study
2019
David M. O'Malley
Aurélien Marabelle
A. De Jesus-Acosta
Sarina Anne Piha-Paul
A. Arkhipov
F. Longo
D. Motola-Kuba
Ronnie Shapira-Frommer
Ravit Geva
Bobbie J. Rimel
Jose A. Lopez-Martin
Aaron Richard Hansen
Janice M. Mehnert
X. Chen
Fan Jin
Kevin Norwood
Patrick A. Ott
Keywords:
Endometrial cancer
General surgery
Internal medicine
Oncology
Medicine
Pathology
Cancer
Delegation (computing)
Response Evaluation Criteria in Solid Tumors
Steering committee
Adenocarcinoma
in patient
Pembrolizumab
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
8
Citations
NaN
KQI
[]